MY01 Inc. is a game-changer in the medical equipment manufacturing industry, having raised an impressive $12.5M in funding from investors Investissement Québec and Fondaction. Founded by Charles Allan, MY01 Inc. is based in Montreal, Quebec, and has a singular mission: to improve patient outcomes by empowering healthcare professionals with the ability to preempt severe medical conditions. MY01 Inc. believes that actionable quantitative data at the bedside can make a meaningful impact on the patient while improving the experience of providing care. The company focuses on delivering actionable data at the bedside to augment clinical assessments, with qualitative people-to-people assessments at the core of personalized healthcare. 

One of the company's key strengths lies in its ability to enable continuous intracompartmental monitoring, providing reliable, and real-time continuous pressure measurements to aid in the diagnosis of compartment syndrome, which can be life-threatening. The MY01 device can continuously measure a patient's intracompartmental pressure for up to 18 hours, allowing for simple yet reliable continuous pressure monitoring. MY01's cutting-edge technology not only helps healthcare professionals make the right call under pressure but can also drive cost savings through more efficient patient care.